Sanofi drops BTK drug tolebrutinib in myasthenia gravis
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
Mounjaro misses for Lilly in Q4, but big surge expected
After referring to the launch of its type 2 diabetes therapy Mounjaro as viral e
Roche names Teresa Graham as its new pharma chief
Bill Anderson's replacement as chief executive of Roche Pharmaceuticals has been announced, with head of global product strategy Teresa Graham stepping up into the role.
Telehealth firm GoodRx fined $1.5m over privacy breach
Telehealth and discount medicines provider GoodRx has been ordered to pay a $1.5 million fine by the US authorities for sharing its customers' sensitive health information
Roche finally drops curtain on AKT drug ipatasertib
In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update<
Sales & marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
2nd Next Generation Kinase Inhibitors Summit
Industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products
5th Cell Engager Summit
The 5th Annual Cell Engager Summit is back in Boston, MA this year
2nd Next Generation RNA Therapeutics Summit
Bringing Next Generation RNA Therapies to Patients Fast
PharmStars Announces "Women's Health" or "Health Equity" The...
PharmStars Accelerator Open for Applications
Ensuring A Zero-Risk Data Privacy Environment When Capturing...
Capturing Medical Insights With Zero-Risk